Trial
NCT06418711
ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Mannkind Corporation
Collaborators
—
Condition
MAC Lung Disease
Intervention
Clofazimine Inhalation Suspension
Why stopped
Futility
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-11-12